Loading clinical trials...
Loading clinical trials...
Extracorporeal Photopheresis (ECP) has been used as one of the treatments for graft versus host disease (GVHD). Responses were observed in skin, liver, GI tract, mouth, eye and lung. ECP does not caus...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Henry Ford Health System
NCT06244628 · cGVHD
NCT04373057 · Acute GVHD
NCT06660355 · Chronic Graft-versus-host Disease (cGVHD)
NCT07253259 · cGVHD
NCT06343792 · Steroid Refractory GVHD
Henry Ford Hospital
Detroit, Michigan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions